What is UCT?
UCT operates as a specialized provider of advanced sample preparation and chromatography solutions, catering to a global clientele that demands high-performance analytical tools. The company's core product portfolio, which includes QuEChERS extraction products, solid phase extraction (SPE) columns, and HPLC columns, is engineered to streamline complex laboratory workflows. By focusing on the intersection of efficiency and accuracy, UCT supports critical industries such as environmental testing, food safety, and pharmaceutical research. Their market position is defined by a long-standing reputation for quality, enabling laboratories to achieve reproducible results while navigating evolving regulatory landscapes.
How much funding has UCT raised?
UCT has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in UCT
PPP
Public-Private Partnership
What's next for UCT?
With this major enterprise-level funding, UCT is well-positioned to accelerate its research and development initiatives, particularly in the refinement of its chromatography product lines. The strategic allocation of these resources will likely focus on expanding the company's reach into emerging markets where demand for high-throughput analytical testing is rising. Furthermore, the investment provides the necessary liquidity to enhance manufacturing capabilities, ensuring that UCT can meet the growing global demand for specialized laboratory consumables. As the company moves into its next growth phase, the focus will remain on maintaining its competitive edge through innovation in sample preparation technology and deepening its integration into the workflows of major forensic and pharmaceutical institutions.
See full UCT company page
